B Zanker

1.6k total citations
48 papers, 1.3k citations indexed

About

B Zanker is a scholar working on Immunology, Transplantation and Oncology. According to data from OpenAlex, B Zanker has authored 48 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Immunology, 17 papers in Transplantation and 11 papers in Oncology. Recurrent topics in B Zanker's work include Renal Transplantation Outcomes and Treatments (16 papers), Neurological Complications and Syndromes (10 papers) and Immune Cell Function and Interaction (9 papers). B Zanker is often cited by papers focused on Renal Transplantation Outcomes and Treatments (16 papers), Neurological Complications and Syndromes (10 papers) and Immune Cell Function and Interaction (9 papers). B Zanker collaborates with scholars based in Germany, United States and Austria. B Zanker's co-authors include Terry B. Strom, Gerd Walz, Mark L. Lipman, W. Land, Dieter Kabelitz, Hermann Wagner, Chris Stevens, Mark A. Peppercorn, Donald A. Antonioli and K J Wieder and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The Journal of Experimental Medicine and The Journal of Immunology.

In The Last Decade

B Zanker

47 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
B Zanker Germany 17 488 448 296 202 202 48 1.3k
Christof Weinstock Germany 22 173 0.4× 532 1.2× 177 0.6× 92 0.5× 197 1.0× 41 1.9k
B. Ryffel Switzerland 19 129 0.3× 517 1.2× 121 0.4× 167 0.8× 119 0.6× 36 1.2k
Christophe Baron France 17 264 0.5× 333 0.7× 142 0.5× 85 0.4× 156 0.8× 39 857
Ghasem Solgi Iran 20 93 0.2× 392 0.9× 128 0.4× 162 0.8× 164 0.8× 93 1.3k
Faouzi Braza France 17 294 0.6× 734 1.6× 275 0.9× 77 0.4× 151 0.7× 25 1.4k
Roy A. Dempsey United States 16 106 0.2× 585 1.3× 206 0.7× 151 0.7× 143 0.7× 30 1.1k
Wolf‐Dietrich Döcke Germany 22 52 0.1× 893 2.0× 116 0.4× 187 0.9× 592 2.9× 31 1.7k
Laureline Berthelot France 25 113 0.2× 836 1.9× 172 0.6× 92 0.5× 162 0.8× 46 1.9k
Tina L. Sumpter United States 25 77 0.2× 1.0k 2.3× 241 0.8× 172 0.9× 319 1.6× 55 1.8k
Pierre‐Joseph Royer France 18 41 0.1× 492 1.1× 168 0.6× 123 0.6× 103 0.5× 38 1.4k

Countries citing papers authored by B Zanker

Since Specialization
Citations

This map shows the geographic impact of B Zanker's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by B Zanker with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites B Zanker more than expected).

Fields of papers citing papers by B Zanker

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by B Zanker. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by B Zanker. The network helps show where B Zanker may publish in the future.

Co-authorship network of co-authors of B Zanker

This figure shows the co-authorship network connecting the top 25 collaborators of B Zanker. A scholar is included among the top collaborators of B Zanker based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with B Zanker. B Zanker is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Köhler, H., B Zanker, & Terry B. Strom. (2008). Immunbiologie der Transplantatabstoßung und deren pharmakologische Beeinflussung. DMW - Deutsche Medizinische Wochenschrift. 116(7). 264–269.
2.
Zanker, B, E Wandel, Gem J. C. Kramer, et al.. (2008). Baclofenintoxikation bei chronischer Hämodialyse und Nierentransplantation. DMW - Deutsche Medizinische Wochenschrift. 117(19). 733–737. 5 indexed citations
3.
Undre, N., J van Hooff, Maarten H. L. Christiaans, et al.. (1999). Low systemic exposure to tacrolimus correlates with acute rejection. Transplantation Proceedings. 31(1-2). 296–298. 148 indexed citations
4.
Schlosser, S, H. Schneeberger, Birgit Lorenz, et al.. (1999). No clinical evidence of hyperlipidemia as a risk factor for chronic renal allograft failure. Transplantation Proceedings. 31(1-2). 1391–1392. 11 indexed citations
5.
Zanker, B, et al.. (1999). Comparison of MPA trough levels in patients with severe diabetes mellitus and from non-diabetics after transplantation. Transplantation Proceedings. 31(1-2). 1167–1167. 7 indexed citations
6.
Undre, Nasrullah, J van Hooff, Maarten H. L. Christiaans, et al.. (1998). Pharmacokinetics of FK 506 and Mycophenolic Acid After the Administration of a FK 506–Based Regimen in Combination With Mycophenolate Mofetil in Kidney Transplantation. Transplantation Proceedings. 30(4). 1299–1302. 36 indexed citations
7.
Vanrenterghem, Yves, J.P. Squifflet, John Forsythe, et al.. (1998). Co-administration of Tacrolimus and Mycophenolate Mofetil in Cadaveric Renal Transplant Recipients. Transplantation Proceedings. 30(4). 1290–1291. 28 indexed citations
8.
Zanker, B, H. Schneeberger, Uwe Rothenpieler, et al.. (1998). MYCOPHENOLATE MOFETIL-BASED, CYCLOSPORINE-FREE INDUCTION AND MAINTENANCE IMMUNOSUPPRESSION. Transplantation. 66(1). 44–49. 63 indexed citations
9.
10.
Barth, Cláudia, et al.. (1996). Restricted T cell Vβ repertoire in renal allografts during acute and chronic rejection. Kidney International. 50(6). 2020–2026. 14 indexed citations
11.
Zanker, B, et al.. (1996). Mycophenolate mofetil in patients with acute renal failure: evidence of metabolite (MPAG) accumulation and removal by dialysis. Transplant International. 9 Suppl 1. 308–310. 7 indexed citations
12.
Stevens, Chris, Gerd Walz, Mark L. Lipman, et al.. (1992). Tumor necrosis factor-?, interleukin-1?, and interleukin-6 expression in inflammatory bowel disease. Digestive Diseases and Sciences. 37(6). 818–826. 280 indexed citations
13.
Sehajpal, P. K., B Zanker, Aruljothi Subramaniam, et al.. (1991). THE MOLECULAR BASIS FOR THE SYNERGISM BETWEEN THE CD3/αβ T CELL RECEPTOR AND THE CD2 ANTIGEN-DERIVED SIGNALS IN PROMOTING T CELL PROLIFERATION. Transplantation. 51(2). 468–474. 5 indexed citations
14.
Almawi, WY, et al.. (1991). Abrogation of glucocorticoid-mediated inhibition of T cell proliferation by the synergistic action of IL-1, IL-6, and IFN-gamma. The Journal of Immunology. 146(10). 3523–3527. 134 indexed citations
15.
Zanker, B, et al.. (1990). POSSIBLE ASSOCIATION OF THE IMMUNOSUPPRESSIVE AND B CELL LYMPHOMA-PROMOTING PROPERTIES OF CYCLOSPORINE. Transplantation. 49(1). 191–193. 47 indexed citations
16.
Wieder, K J, Gerd Walz, B Zanker, et al.. (1990). Physiologic signaling in normal human T-cells: mRNA phenotyping by northern blot analysis and reverse transcription-polymerase chain reaction. Cellular Immunology. 128(1). 41–51. 7 indexed citations
17.
Zanker, B, et al.. (1989). SIMILAR EFFECTS OF CYCLOSPORINE AND VERAPAMIL ON LYMPHOKINE, INTERLEUKIN 2 RECEPTOR, AND PROTO-ONCOGENE EXPRESSION. Transplantation. 47(2). 331–333. 9 indexed citations
18.
Zanker, B, et al.. (1988). Quantitative assessment of interleukin-2-producing alloreactive human T cells by limiting dilution analysis. Journal of Immunological Methods. 112(1). 85–90. 25 indexed citations
19.
Zanker, B, et al.. (1988). Cyclosphorine sensitivity in renal transplant patients. Quantitative assessment of interleukin-2-producing alloreactive helper T cells by limiting dilution analysis.. PubMed. 46(2). 313–6. 1 indexed citations
20.
Meuer, Stefan, B Zanker, U. Hadding, & D Bitter-Suermann. (1982). Low zone desensitization: a stimulus-specific control mechanism of cell response. Investigations on anaphylatoxin-induced platelet secretion.. The Journal of Experimental Medicine. 155(3). 698–710. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Christof Weinstock Breakdown of academic impact, for papers by B. Ryffel Breakdown of academic impact, for papers by Christophe Baron Breakdown of academic impact, for papers by Ghasem Solgi Breakdown of academic impact, for papers by Faouzi Braza Breakdown of academic impact, for papers by Roy A. Dempsey Breakdown of academic impact, for papers by Wolf‐Dietrich Döcke Breakdown of academic impact, for papers by Laureline Berthelot Breakdown of academic impact, for papers by Tina L. Sumpter Breakdown of academic impact, for papers by Pierre‐Joseph Royer
Rankless by CCL
2026